Investing in the promise of research
As part of our Life.Changes. campaign, we’re raising $12 million to support the new Bridgepoint Collaboratory for Research and Innovation – including Canada’s first academic Chair in Complex Chronic Disease Research, in collaboration with the University of Toronto.
The Collaboratory is led by Dr. Renée Lyons, an internationally recognized scientist. She is the first Bridgepoint Chair in Complex Chronic Disease Research and also the TD Financial Group, Scientific Director, Bridgepoint Collaboratory for Research and Innovation. Learn more about Dr. Lyons
“Complex chronic disease has the potential to overwhelm our healthcare system. At the same time, evidence shows that we are underperforming in prevention and treatments. We need the right research to turn the story around – and we need investors who are committed to building a solid foundation for that research.”
- Dr. Renée Lyons
You can advance the prevention and treatment of complex chronic disease
By investing in the Bridgepoint Collaboratory for Research and Innovation, you’ll be supporting a unique approach to health research that will improve the quality of life for people with complex chronic disease. And by providing essential leverage to secure academic grants, your investment will have far-reaching impact.
Learn more about Bridgepoint’s research enterprise